| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Elevance Health, Inc. (ELV) has 14 insiders with recent SEC Form 4 filings, including 5 buys and 12 sells. ELV is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 151.0K | $56.32M | - | |
| CFO | 16.1K | $6.00M | - | |
| Dir | 11.5K | $4.29M | - | |
| Dir | 10.3K | $3.85M | - | |
| Dir | 9.6K | $3.59M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Collis Steven H | Director | Buy | 3,000 | $289.84 | $869,520.00 | +469.5% | - | - | |
| Aug 19, 2025 | Devore Susan D. | Director | Buy | 1,200 | $312.15 | $374,580.00 | +52.1% | +6.1% | - | |
| Jul 18, 2025 | Boudreaux Gail | President And CEO | Buy | 8,500 | $286.94 | $2,438,951.30 | +1.9% | +25.7% | - | |
| Apr 24, 2025 | Kaye Mark63 | EVP &CFO | Sell | 4,588 | $424.82 | $1,949,074.16 | -19.5% | -30.8% | -19.6% | |
| Mar 10, 2025 | Penczek Ronald W52 | CAO &Controller | Sell | 443 | $415.13 | $183,902.59 | -19.3% | -4.9% | -31.0% | |
| Mar 5, 2025 | Kendrick Charles Morgan Jr60 | EVP &President, Commercial | Sell | 3,504 | $396.30 | $1,388,635.20 | -25.7% | -4.7% | -27.9% | |
| Oct 18, 2024 | Kendrick Charles Morgan Jr60 | EVP &President, Commercial | Sell | 7,417 | $432.14 | $3,205,182.38 | -46.8% | -10.6% | -19.0% | |
| Aug 5, 2024 | Peru Ramiro G55 | Director | Sell | 753 | $531.52 | $400,234.56 | -7.9% | -20.2% | -47.2% | |
| Jul 22, 2024 | Boudreaux Gail | President And CEO | Sell | 34,000 | $500.98 | $17,033,394.84 | -4.0% | -16.2% | -44.1% | |
| Jul 19, 2024 | Dixon Robert L Jr63 | Director | Sell | 305 | $506.76 | $154,561.80 | -3.0% | -11.2% | -44.6% |